Lexicon Pharmaceuticals (LXRX) Times Interest Earned (2010 - 2023)
Lexicon Pharmaceuticals (LXRX) reported Times Interest Earned of -$12.73 for Q3 2023, up 52.38% year-over-year from -$8.35 in Q3 2022, and up 43.6% quarter-over-quarter from -$22.57 in Q2 2023.
Lexicon Pharmaceuticals (LXRX) Times Interest Earned (2010 - 2023) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 14 years of Times Interest Earned data on file, last reported at -$12.73 in Q3 2023.
- Times Interest Earned for Q3 2023 came in at -$12.73, up 52.38% year-over-year; the trailing twelve-month figure through Jun 2024 was -$50.54 (down 125.62% YoY), and the FY2022 annual result was -$36.24, up 66.62% from the prior year.
- Times Interest Earned rose to -$12.73 in Q3 2023 per LXRX's latest filing, from -$22.57 in the prior quarter.
- Over five years, Times Interest Earned peaked at $43.17 in Q3 2019 and troughed at -$212.55 in Q1 2022.
- A 5-year average of -$43.42 and a median of -$22.57 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2019 and 2021: Times Interest Earned surged 1089.0% in 2019, then plunged 925.45% in 2021.
- A 5-year view of Times Interest Earned shows it stood at -$9.1 in 2019, then tumbled by 382.31% to -$43.87 in 2020, then slumped by 95.72% to -$85.86 in 2021, then jumped by 68.03% to -$27.45 in 2022, then jumped by 53.63% to -$12.73 in 2023.
- Business Quant data shows LXRX's Times Interest Earned at -$12.73 in Q3 2023, -$22.57 in Q2 2023, and -$17.1 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -12.73 |
| Jun 30, 2023 | -22.57 |
| Mar 31, 2023 | -17.10 |
| Dec 31, 2022 | -27.45 |
| Sep 30, 2022 | -26.73 |
| Jun 30, 2022 | -34.15 |
| Mar 31, 2022 | -212.55 |
| Dec 31, 2021 | -85.86 |
| Sep 30, 2021 | -134.28 |
| Jun 30, 2021 | -106.27 |
| Mar 31, 2021 | -124.78 |
| Dec 31, 2020 | -43.87 |
| Sep 30, 2020 | 21.05 |
| Jun 30, 2020 | -12.60 |
| Mar 31, 2020 | -12.17 |
| Dec 31, 2019 | -9.10 |
| Sep 30, 2019 | 43.17 |
| Jun 30, 2019 | -3.59 |
| Mar 31, 2019 | -3.41 |
| Dec 31, 2018 | -2.37 |